Provider Resources WA

Health Advisory: Measles increasing in Washington, the nation, and the globe

| March 28, 2024

Please note that this is an update related to an earlier advisory on the worldwide spread of measles. Read the original advisory here. Summary Background Measles is a highly contagious viral illness that can lead to severe health complications, like pneumonia, encephalitis, and death, especially in unvaccinated people. Measles outbreaks have occurred in Washington, the … Health Advisory: Measles increasing in Washington, the nation, and the globe

Health Advisory: RSV prevention updates

| February 15, 2024
Infant sleeping on adult's chest.

Summary Background On Oct. 23, 2023, Centers for Disease Control and Prevention (CDC) issued a health alert about the limited supply of nirsevimab. CDC recommended healthcare providers prioritize nirsevimab for infants born later in RSV (respiratory syncytial virus) season or for those at increased risk for severe illness. On Jan. 5, 2024, CDC issued updated guidance about the increased … Health Advisory: RSV prevention updates

Health Advisory: Nirsevimab supplies limited

| November 22, 2023
Provider standing and pregnant person sitting on exam table.

Nov. 22, 2023 Washington is scheduled to receive 7,700 50 mg and 600 100 mg Pfizer nirsevimab doses for the remainder of respiratory syncytial virus (RSV) season. The CDC released a Health Alert that provides guidance for healthcare providers. See the background section below for details.  ACTIONS REQUESTED Immunize.org released a standing order template for this RSV season to ensure … Health Advisory: Nirsevimab supplies limited

Health Advisory: FDA authorized new Novavax COVID-19 vaccine formulation

| October 19, 2023

Actions requested BE AWARE that on Oct. 3, 2023, U.S. Food and Drug Administration (FDA) authorized for emergency use a new adjuvanted (2023–2024) formulation of Novavax COVID-19 vaccine for people 12 years or older. BE AWARE that the FDA deauthorized the original Novavax COVID-19 vaccine. BE AWARE that the new adjuvanted (2023–2204) formulation of Novavax COVID-19 vaccine is … Health Advisory: FDA authorized new Novavax COVID-19 vaccine formulation

Health Advisory: New COVID-19 vaccines authorized, previous bivalent COVID-19 vaccines deauthorized

| September 20, 2023
syringe in vial

Actions requested BE AWARE that on Sept. 11, 2023, the U.S. Food and Drug Administration (FDA) approved and/or authorized for emergency use new, updated (2023–2024) COVID-19 vaccines from Moderna and Pfizer. Then, on Sept. 12, 2023, Centers for Disease Control and Prevention (CDC) recommended everyone 6 months or older get a new, updated (2023–2024) COVID-19 vaccine. … Health Advisory: New COVID-19 vaccines authorized, previous bivalent COVID-19 vaccines deauthorized

05/12/22 Health Advisory: FDA Limits Use of Johnson & Johnson COVID-19 Vaccine.

| May 12, 2022
Syringe in vial

Requested actions Background FDA limited the authorized use of J&J to people age 18 years and older: This decision came after FDA analyzed, evaluated and investigated reported cases of TTS after getting J&J. TTS is rare and includes potentially life-threatening blood clots in combination with low levels of blood platelets. Symptoms typically start 1–2 weeks … 05/12/22 Health Advisory: FDA Limits Use of Johnson & Johnson COVID-19 Vaccine.

05/05/22 Health Advisory: Colorado person first U.S. case of H5 bird flu

| May 5, 2022

A person in Colorado tested positive for avian influenza A(H5N1) virus (H5 bird flu), Colorado Department of Public Health and Environment reported April 28, 2022. Centers for Disease Control and Prevention (CDC) confirmed it is the first U.S. case of H5 bird flu. The person was involved in the culling of poultry with presumptive H5 … 05/05/22 Health Advisory: Colorado person first U.S. case of H5 bird flu

04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses eligibility for second booster dose of COVID-19 vaccine

| April 27, 2022
hands in blue medical gloves holding a syringe and drawing from a vile

Requested actions Be aware, on April 25, 2022, Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) advisory about the availability and use of recommended COVID-19 therapies. It also advised against using unproven treatments that have known or potential harm. Follow National Institutes of Health (NIH) COVID-19 treatment guidelines and use … 04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses eligibility for second booster dose of COVID-19 vaccine

04/08/22 Health Advisory: COVID-19 Information for Providers

| April 8, 2022
Female doctor with file in front of them with two other doctors at a microscope in the background.

Requested actions Be aware, on March 29, 2022, Food and Drug Administration (FDA) amended its emergency use authorization (EUA) for Moderna COVID-19 booster dose vaccine. A new multi-dose vial is now available. It has a dark blue cap and a label with a purple border. Doses from this vial are 0.5 mL. Multi-dose vials are … 04/08/22 Health Advisory: COVID-19 Information for Providers

03/30/22 Health Advisory: CDC endorses second booster dose of mRNA COVID-19 vaccine for certain groups

| March 30, 2022
Syringe in vial

Requested actions Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup endorsed Food and Drug Administration’s (FDA’s) emergency use authorization (EUA) of a second booster dose of Pfizer or Moderna COVID-19 vaccines for specific groups. The EUA allows: A second booster dose of Pfizer COVID-19 vaccine at least … 03/30/22 Health Advisory: CDC endorses second booster dose of mRNA COVID-19 vaccine for certain groups